Hi Tech Pharmaceuticals – Megadrine RFA-1 Hi-Tech Pharmaceuticals: Compound Profile
Megadrine RFA-1 is a standardised ephedra extract formulation developed by Hi-Tech Pharmaceuticals for research applications investigating thermogenic and metabolic pathways. This compound represents a refined alkaloid fraction (RFA-1) derived from Ephedra sinica, standardised for consistent research outcomes. Scientists at Stroid UK Shop frequently study this extract in conjunction with other metabolic modulators to investigate complex thermogenic mechanisms in controlled laboratory environments.
Research Applications
In laboratory studies, researchers examine Megadrine RFA-1 for its effects on cellular energy expenditure and thermogenic pathway activation. The standardised alkaloid profile makes it valuable for investigating beta-adrenergic receptor interactions and their downstream metabolic cascades. Research teams often compare this extract with synthetic compounds from our ephedra extract collection to evaluate natural versus synthetic pathway modulation. Studies frequently investigate synergistic effects when combined with compounds from our SARMs range or peptide compounds for comprehensive metabolic research protocols.
Product Specifications
| Product Name | Hi-Tech Pharmaceuticals Megadrine RFA-1 |
|---|---|
| SKU | EU23016 |
| Classification | Ephedra extract (alkaloid fraction) |
| Active Components | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Requirements | Room temperature, dry environment |
| Shelf Life | As per manufacturer specifications |
| Research Grade | Laboratory use only |
Compliance Statement
This product is sold strictly for in-vitro research and laboratory analysis only. Megadrine RFA-1 is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must comply with all applicable regulations governing laboratory chemical handling and safety protocols.
